DGX 159.37 (+2.03%)
US74834L1008Medical Diagnostics & ResearchDiagnostics & Research

Quest Diagnostics (DGX) Stock Highlights

159.37 | +2.03%
2024-11-09 00:52:00
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.

Statistics

Range Today
155.79 160.46
Volume Today 766.62K
Range 1 Year
123.04 160.95
Volume 1 Year 228.91M
Range 3 Year
119.59 174.16
Volume 3 Year 754.14M
Range 10 Year
59.66 174.16
Volume 10 Year 2.84B

Highlights

Market Capitalization 17.79B (large)
Floating Shares 110.69M
Current Price 159.37
Price To Earnings 20.95
Price To Revenue 2.49
Price To Book 2.62
Earnings Per Share 7.44
Dividend Yield 1.92%
Dividend Per Share 3
Payout Ratio 39.78%

Performance

Latest +2.03%
1 Month +8.26%
3 Months +9.28%
6 Months +16.14%
1 Year +19.13%
3 Years +13.32%
5 Years +56.8%
10 Years +157.92%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.